{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:09:42Z","timestamp":1786118982469,"version":"build-2736575974"},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1097\/ico.0b013e318172fbc5","type":"journal-article","created":{"date-parts":[[2008,8,21]],"date-time":"2008-08-21T06:14:43Z","timestamp":1219299283000},"page":"967-969","source":"Crossref","is-referenced-by-count":7,"title":["Intravenous Immunoglobulin Therapy for Refractory Ocular Cicatricial Pemphigoid: Case Report"],"prefix":"10.1097","volume":"27","author":[{"given":"Marta","family":"Galdos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Etxebarr\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-26-20210204","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.preteyeres.2004.05.005","article-title":"Ocular cicatricial pemphigoid: pathogenesis, diagnosis and treatment.","volume":"23","author":"Ahmed","year":"2004","journal-title":"Prog Retin Eye Res"},{"key":"R2-26-20210204","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0161-6420(01)00863-6","article-title":"The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid.","volume":"109","author":"Miserocchi","year":"2002","journal-title":"Ophthalmology"},{"key":"R3-26-20210204","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1016\/S0161-6420(99)90496-7","article-title":"Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: a preliminary study.","volume":"106","author":"Foster","year":"1999","journal-title":"Ophthalmology"},{"key":"R4-26-20210204","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.ophtha.2003.11.012","article-title":"Intravenous immunoglobulin therapy in patients with ocular-cicatricial pemphigoid: a long term follow-up.","volume":"111","author":"Sami","year":"2004","journal-title":"Ophthalmology"},{"key":"R5-26-20210204","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archderm.139.8.1051","article-title":"Consensus statement on the use of IVIg in treatment of autoimmune mucocutaneous blistering diseases.","volume":"139","author":"Ahmed","year":"2003","journal-title":"Arch Dermatol"},{"key":"R6-26-20210204","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.clim.2003.11.002","article-title":"A non-randomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies.","volume":"111","author":"Letko","year":"2004","journal-title":"Clin Inmunol"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00003226-200809000-00026","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:14:11Z","timestamp":1786036451000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00003226-200809000-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":6,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e318172fbc5","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}